Spero Therapeutics SPRO
NASDAQ SPRO
$1.17 -0.05 (-4.10%)
At close: Oct 21, 2026 · 4:00 PM EDT

Spero Therapeutics (SPRO) Non-Current Assets (2016 - 2026)

Updated

Spero Therapeutics (SPRO) recorded Non-Current Assets of $1.18 million in Q2 2026, down 56.5% from $2.72 million a year earlier and down 16.1% from the prior quarter.

Analysis

Spero Therapeutics (SPRO) Non-Current Assets (2016 - 2026) Analysis & Trends

At the end of FY2025, Spero Therapeutics reported Non-Current Assets of $1.63 million, down 50.0% from FY2024.

  • Annual Non-Current Assets has a five-year compound annual growth rate of -35.2% (FY2020 to FY2025).
  • Across earlier years, Non-Current Assets came in at $3.27 million in FY2024 (-93.6%), $51.18 million in FY2023 (+355.7%), $11.23 million in FY2022 (-14.9%) and $13.2 million in FY2021 (-7.7%).
  • The Q2 2026 figure is the lowest quarterly Non-Current Assets in data going back to Q4 2016.
  • On a year-over-year basis, Non-Current Assets has declined for eight consecutive quarters, with an average decline of 63.5% over the last eight quarters.
  • Peak year-over-year performance for Non-Current Assets in the last five years was growth of 355.7% in Q4 2023, against a decline of 93.6% in Q4 2024 at the low end.
  • Per Business Quant, the preceding three quarters came in at $1.41 million (Q1 2026), $1.63 million (Q4 2025) and $1.85 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 77.61 Bn
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 141.29 Bn
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 101.45 Bn
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 125.00 Mn
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 94.68 Bn
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 87.87 Bn
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 60.68 Bn
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn 35.42 Bn
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 159.77 Bn
10 Spero Therapeutics 68.40 Mn -127.38 Mn - 1.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.18 Mn
Mar 31, 2026 1.41 Mn
Dec 31, 2025 1.63 Mn
Sep 30, 2025 1.85 Mn
Jun 30, 2025 2.72 Mn
Mar 31, 2025 3.00 Mn
Dec 31, 2024 3.27 Mn
Sep 30, 2024 3.53 Mn
Jun 30, 2024 27.66 Mn
Mar 31, 2024 27.55 Mn
Dec 31, 2023 51.18 Mn
Sep 30, 2023 4.88 Mn
Jun 30, 2023 10.54 Mn
Mar 31, 2023 10.88 Mn
Dec 31, 2022 11.23 Mn
Sep 30, 2022 11.59 Mn
Jun 30, 2022 11.67 Mn
Mar 31, 2022 13.13 Mn
Dec 31, 2021 13.20 Mn
Sep 30, 2021 12.92 Mn
API Access

Spero Therapeutics Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-assets&ticker=SPRO&period=max&api_key=YOUR_API_KEY